Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Ovarian Neoplasms

  Free Subscription


15.09.2025

2 Am J Obstet Gynecol
1 Cancer Lett
2 Eur J Obstet Gynecol Reprod Biol
1 Gynecol Oncol
1 Oncogene


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Obstet Gynecol

  1. MEYER LA, Ishizawa S, Toumazis I
    Use of a Natural History Model to Benchmark Progress in Managing Ovarian Cancer (Reply to Letter-to-the-Editor).
    Am J Obstet Gynecol. 2025 Sep 10:S0002-9378(25)00658.
    PubMed        

  2. MENG R
    Enhancing Clinical Translatability of Histology-Specific Ovarian Cancer Natural History Models (Letter-to-the-Editor).
    Am J Obstet Gynecol. 2025 Sep 10:S0002-9378(25)00659.
    PubMed        


    Cancer Lett

  3. EL BABA R, Haidar Ahmad S, Vanhulle C, Vreux L, et al
    Formation of polyploid giant cancer cells and the transformative role of human cytomegalovirus IE1 protein.
    Cancer Lett. 2025;630:217824.
    PubMed         Abstract available


    Eur J Obstet Gynecol Reprod Biol

  4. KHASTGIR G, Siwatch S, Singh T, Jain V, et al
    Beyond the Image: Performance of O-RADS, ADNEX, IOTA Simple Rules & RMI 4 in differentiating benign and malignant adnexal masses - An Indian perspective.
    Eur J Obstet Gynecol Reprod Biol. 2025;313:114585.
    PubMed         Abstract available

  5. WANG Y, Wang T, Zhou H, Zhang Y, et al
    Oncological and reproductive outcomes of fertility-sparing surgery in young women with early-stage ovarian clear cell carcinoma: A retrospective cohort study.
    Eur J Obstet Gynecol Reprod Biol. 2025;313:114555.
    PubMed         Abstract available


    Gynecol Oncol

  6. YOH K, Desai VB, Gross CP, Spatz ES, et al
    Physician variation in adopting opportunistic salpingectomy at the time of postpartum and interval sterilization for ovarian cancer risk reduction.
    Gynecol Oncol. 2025;202:1-13.
    PubMed         Abstract available


    Oncogene

  7. HUANG L, Zhu M, Chen M, Ying F, et al
    LEF1 confers resistance to DNA-damaging chemotherapies through upregulation of PARP1 and NUMA1 in ovarian cancer.
    Oncogene. 2025 Sep 10. doi: 10.1038/s41388-025-03561.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.